Provider

The AI company now has a presence among more than 500 U.S. hospitals.

Marianna Imenokhoeva, founder at LinktoMedicine and Future50 International, writes about telehealth and its practicalities during the coronavirus pandemic.

Customers can also act as a sponsor, purchasing tests for key workers and vulnerable people

The HIMSS Media team gives a recap of recent headlines surrounding the FDA, COVID-19 and new digital health software products.

Also: Providence supporting COVID-19 patients at home with Xealth and Twistle; Lief Therapeutics incorporates DrChrono's Open API.

Users can choose from 100 conditions and get information about telemedicine pricing and medication services. 

The new website and app were born out of a partnership with Apple, the CDC, the White House Coronavirus Task Force and FEMA.

Both efforts are employing popular consumer wearables and health trackers to spot potential cases of COVID-19 or other viral diseases as they begin.

Dr. Yuri Maricich, chief medical officer at Pear Therapeutics, speaks on his company's experience bringing a digital therapeutic product through the regulator's experimental program for health software.

Somryst, a prescription digital therapeutic combining cognitive behavioral therapy and personalized sleep restriction, is the first software product to put the FDA's early Precertification Program framework through its paces.